PL2755649T3 - Zastosowanie 3-(R)-[3-(2-metoksyfenylotio)-2-(S)-metylopropylo]amino-3,4-dihydro-2H-1,5-benzoksatiepiny w zapobieganiu i/lub leczeniu skutków kardiotoksycznych spowodowanych chemioterapią i/lub promieniowaniem - Google Patents

Zastosowanie 3-(R)-[3-(2-metoksyfenylotio)-2-(S)-metylopropylo]amino-3,4-dihydro-2H-1,5-benzoksatiepiny w zapobieganiu i/lub leczeniu skutków kardiotoksycznych spowodowanych chemioterapią i/lub promieniowaniem

Info

Publication number
PL2755649T3
PL2755649T3 PL12759430T PL12759430T PL2755649T3 PL 2755649 T3 PL2755649 T3 PL 2755649T3 PL 12759430 T PL12759430 T PL 12759430T PL 12759430 T PL12759430 T PL 12759430T PL 2755649 T3 PL2755649 T3 PL 2755649T3
Authority
PL
Poland
Prior art keywords
benzoxathiepine
methoxyphenylthio
methylpropyl
chemotherapy
dihydro
Prior art date
Application number
PL12759430T
Other languages
English (en)
Inventor
Bernard Vacher
Grand Bruno Le
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of PL2755649T3 publication Critical patent/PL2755649T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12759430T 2011-09-13 2012-09-13 Zastosowanie 3-(R)-[3-(2-metoksyfenylotio)-2-(S)-metylopropylo]amino-3,4-dihydro-2H-1,5-benzoksatiepiny w zapobieganiu i/lub leczeniu skutków kardiotoksycznych spowodowanych chemioterapią i/lub promieniowaniem PL2755649T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1158155A FR2979822B1 (fr) 2011-09-13 2011-09-13 Utilisation du 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methyl-propyl]amino-3,4-dihydro-2h-1,5-benzoxathiepine pour la prevention et/ou le traitement des effets cardiotoxiques dus a la chimiotherapie et/ou les rayonnements
EP12759430.7A EP2755649B1 (fr) 2011-09-13 2012-09-13 Utilisation de la 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methyl-propyl]amino-3,4-dihydro-2h-1,5-benzoxathiepine pour la prevention et/ou le traitement des effets cardiotoxiques dus a la chimiotherapie et/ou les rayonnements

Publications (1)

Publication Number Publication Date
PL2755649T3 true PL2755649T3 (pl) 2017-08-31

Family

ID=46851986

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12759430T PL2755649T3 (pl) 2011-09-13 2012-09-13 Zastosowanie 3-(R)-[3-(2-metoksyfenylotio)-2-(S)-metylopropylo]amino-3,4-dihydro-2H-1,5-benzoksatiepiny w zapobieganiu i/lub leczeniu skutków kardiotoksycznych spowodowanych chemioterapią i/lub promieniowaniem

Country Status (7)

Country Link
US (1) US9433603B2 (pl)
EP (1) EP2755649B1 (pl)
ES (1) ES2617485T3 (pl)
FR (1) FR2979822B1 (pl)
HU (1) HUE033355T2 (pl)
PL (1) PL2755649T3 (pl)
WO (1) WO2013037905A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118059234A (zh) * 2024-04-19 2024-05-24 天津市肿瘤医院空港医院 抗pd-1单抗联合米托蒽醌脂质体在制备治疗肿瘤心脏并发症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822467B1 (fr) 2001-03-22 2003-12-12 Pf Medicament Derives benzoxathiepines et leur utilisation comme medicaments
BR0215389A (pt) * 2001-12-28 2004-10-26 Takeda Chemical Industries Ltd Agente preventivo ou terapêutico para distúrbio urinário, método para prevenir ou tratar distúrbio urinário, uso de um composto, composto, pró-droga, processo para preparar o composto, medicamento, e, método para triar um composto
WO2011003129A1 (en) * 2009-07-09 2011-01-13 Ozteo Pty Ltd Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers

Also Published As

Publication number Publication date
FR2979822A1 (fr) 2013-03-15
US20140235692A1 (en) 2014-08-21
ES2617485T3 (es) 2017-06-19
EP2755649A1 (fr) 2014-07-23
EP2755649B1 (fr) 2016-12-14
HUE033355T2 (hu) 2017-11-28
US9433603B2 (en) 2016-09-06
WO2013037905A1 (fr) 2013-03-21
FR2979822B1 (fr) 2015-05-08

Similar Documents

Publication Publication Date Title
HUS1900040I1 (hu) Makrociklusos származékok proliferatív betegségek kezelésére
HUS2200017I1 (hu) Dihidronaftiridinek és rokon vegyületek, amelyek hasznosak kináz inhibitorokként proliferatív betegségek kezelésére
HK1186737A1 (en) Derivatives of azaindazole or diazaindazole type as medicament
IL232530B (en) A combination of factors for cancer treatment
ZA201308617B (en) Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections
EP2671586A4 (en) PHARMACOTHERAPY FOR THE PREVENTION OR TREATMENT OF GLAUCOMA
PL2755649T3 (pl) Zastosowanie 3-(R)-[3-(2-metoksyfenylotio)-2-(S)-metylopropylo]amino-3,4-dihydro-2H-1,5-benzoksatiepiny w zapobieganiu i/lub leczeniu skutków kardiotoksycznych spowodowanych chemioterapią i/lub promieniowaniem
HUP1100290A2 (en) Combination compositions for the treatment of proliferative diseases
HK1193038A1 (zh) -甲氧基苯硫基 -甲基-丙基 氨基- -二氫- -苯並巰氧雜卓用於治療癌症特別是用於預防和/或治療癌症轉移的用途
GB201121228D0 (en) Novel compounds and improved treatments for glaucoma
EP2696872A4 (en) TREATMENT OF GLAUCOMA